Skip to main content
. 2019 Mar 1;30(4):e59. doi: 10.3802/jgo.2019.30.e59

Fig. 3. Comparison of PFS between patients with high (solid line), and low (dashed line) peritoneal cisplatin Cmax.

Fig. 3

PFS, progression-free survival.